The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Lifestyle associated factors such as smoking, overweight, old-age pregnancy, and excessive use of estrogen supplements are some of the major causes of pulmonary embolism.
The global Pulmonary Embolism Therapeutics market was valued at US$ 2236 million in 2023 and is anticipated to reach US$ 4273.3 million by 2030, witnessing a CAGR of 9.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pulmonary Embolism Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Embolism Therapeutics.
Report Scope
The Pulmonary Embolism Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pulmonary Embolism Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pulmonary Embolism Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Boehringer Ingelheim International
- Bristol-Myers Squibb
- Daiichi Sankyo
- F. Hoffmann-La Roche
- Johnson & Johnson
Segment by Type
- Oral
- Parenteral
Segment by Application
- Adult
- Child
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pulmonary Embolism Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Embolism Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Pulmonary Embolism Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Embolism Therapeutics Market Perspective (2019-2030)
2.2 Pulmonary Embolism Therapeutics Growth Trends by Region
2.2.1 Global Pulmonary Embolism Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pulmonary Embolism Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Pulmonary Embolism Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Pulmonary Embolism Therapeutics Market Dynamics
2.3.1 Pulmonary Embolism Therapeutics Industry Trends
2.3.2 Pulmonary Embolism Therapeutics Market Drivers
2.3.3 Pulmonary Embolism Therapeutics Market Challenges
2.3.4 Pulmonary Embolism Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Embolism Therapeutics Players by Revenue
3.1.1 Global Top Pulmonary Embolism Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Pulmonary Embolism Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Pulmonary Embolism Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pulmonary Embolism Therapeutics Revenue
3.4 Global Pulmonary Embolism Therapeutics Market Concentration Ratio
3.4.1 Global Pulmonary Embolism Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Embolism Therapeutics Revenue in 2023
3.5 Pulmonary Embolism Therapeutics Key Players Head office and Area Served
3.6 Key Players Pulmonary Embolism Therapeutics Product Solution and Service
3.7 Date of Enter into Pulmonary Embolism Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Embolism Therapeutics Breakdown Data by Type
4.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Type (2025-2030)
5 Pulmonary Embolism Therapeutics Breakdown Data by Application
5.1 Global Pulmonary Embolism Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Pulmonary Embolism Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pulmonary Embolism Therapeutics Market Size (2019-2030)
6.2 North America Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
6.4 North America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pulmonary Embolism Therapeutics Market Size (2019-2030)
7.2 Europe Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
7.4 Europe Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Embolism Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Pulmonary Embolism Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Pulmonary Embolism Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pulmonary Embolism Therapeutics Market Size (2019-2030)
9.2 Latin America Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Embolism Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Pulmonary Embolism Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Pulmonary Embolism Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim International
11.1.1 Boehringer Ingelheim International Company Detail
11.1.2 Boehringer Ingelheim International Business Overview
11.1.3 Boehringer Ingelheim International Pulmonary Embolism Therapeutics Introduction
11.1.4 Boehringer Ingelheim International Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.1.5 Boehringer Ingelheim International Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Pulmonary Embolism Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Detail
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Pulmonary Embolism Therapeutics Introduction
11.3.4 Daiichi Sankyo Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.3.5 Daiichi Sankyo Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Pulmonary Embolism Therapeutics Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Pulmonary Embolism Therapeutics Introduction
11.5.4 Johnson & Johnson Revenue in Pulmonary Embolism Therapeutics Business (2019-2024)
11.5.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
